Brief Internet Based Treatment for PTSD
|ClinicalTrials.gov Identifier: NCT01760213|
Recruitment Status : Unknown
Verified December 2012 by Hadassah Medical Organization.
Recruitment status was: Not yet recruiting
First Posted : January 4, 2013
Last Update Posted : May 23, 2013
The goal of the project is to overcome some of the common barriers to treatment amongst recent survivors of traumatic events, by combining the world of evidence-based intervention with that of modern Internet technology. Specifically, it aims to test the feasibility and effectiveness of an Internet delivery of early-intervention trauma-focused cognitive behavioral therapy (CBT) for preventing post-traumatic stress disorder (PTSD). Over the course of the study the following objectives will be achieved:
- The development of an Internet-based Virtual Reality intervention for preventing PTSD among patients who have recently experienced a traumatic event.
- The evaluation of the feasibility of administering this intervention, and
- The evaluation of the efficacy of this Internet based intervention in the prevention of PTSD in recent trauma survivors.
|Condition or disease||Intervention/treatment||Phase|
|PTSD||Other: CBT delivered via Internet||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||900 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Internet Based Treatment Using Virtual Reality in the Prevention of PTSD|
|Study Start Date :||January 2013|
|Estimated Primary Completion Date :||January 2015|
|Estimated Study Completion Date :||August 2015|
intervention delivered via internet
|Other: CBT delivered via Internet|
|No Intervention: Control|
- Levels of PTSD symptoms [ Time Frame: 12 months after end of treatment ]the main outcome measure will be PTSD symptoms as measured by the CAPS.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01760213
|Hadassah medical organization||Not yet recruiting|
|Jerusalem, Israel, 91200|
|Principal Investigator:||Rena Cooper, MD||HMO|
|Study Director:||Sara Freedman, PhD||Bar Ilan University|